Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Related Articles by Review for PubMed (Select 21224201)

1.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Watts NB, Bilezikian JP, Camacho PM, Greenspan SL, Harris ST, Hodgson SF, Kleerekoper M, Luckey MM, McClung MR, Pollack RP, Petak SM; AACE Osteoporosis Task Force.

Endocr Pract. 2010 Nov-Dec;16 Suppl 3:1-37. No abstract available.

PMID:
21224201
2.

[Current approaches to the diagnosis and treatment of postmenopausal osteoporosis].

Baranova IA.

Ter Arkh. 2009;81(10):56-60. Review. Russian.

PMID:
19947443
3.

[Drug treatment of postmenopausal osteoporosis. What's New in 2006].

Roux C, Briot K, Dumarcet N, Bourgoin M, Chapurlat R, Christin-Maitre S, Cortet B, Costagliola D, Diebolt V, Lacoin F, Letombe B, Oberlin F, Orcel P, Ravaud P, Seret P, Thomas T, Vogel JY, Barna A, Nouyrigat E, Veyries ML, Yoldjian I.

Presse Med. 2006 Oct;35(10 Pt 2):1529-39. Review. French. No abstract available.

PMID:
17028517
4.

[Practical guidelines for the management of osteoporosis--evidence-based and cost-effective].

Bartl R.

Dtsch Med Wochenschr. 2007 May 4;132(18):995-9. Review. German. No abstract available.

PMID:
17457784
5.
6.

Preventing osteoporosis-related fractures: an overview.

Gass M, Dawson-Hughes B.

Am J Med. 2006 Apr;119(4 Suppl 1):S3-S11. Review.

PMID:
16563939
7.

Review of postmenopausal osteoporosis pharmacotherapy.

Mayes SL.

Nutr Clin Pract. 2007 Jun;22(3):276-85. Review.

PMID:
17507728
8.

Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide.

Heinemann DF.

Geriatrics. 2000 May;55(5):31-6; quiz 39. Review.

PMID:
10826263
9.

Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.

Palacios S.

Curr Med Res Opin. 2010 Jul;26(7):1553-63. doi: 10.1185/03007991003795873. Review.

PMID:
20429824
10.

[Follow-up of osteoporosis treatment].

Lespessailles E.

Presse Med. 2006 Oct;35(10 Pt 2):1565-70. Review. French.

PMID:
17028522
11.

What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?

Miller PD, Derman RJ.

Osteoporos Int. 2010 Nov;21(11):1793-802. doi: 10.1007/s00198-010-1208-3. Epub 2010 Mar 23. Review.

PMID:
20309524
12.

[Therapeutic agents for disorders of bone and calcium metabolism--Teriparatide, parathyroid hormone (1-34) as a daily subcutaneous injection].

Hashimoto Y, Wakayama N, Miyauchi A.

Clin Calcium. 2007 Jan;17(1):48-55. Review. Japanese.

PMID:
17211093
13.

Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.

Rossini M, Viapiana O, Gatti D, Adami S.

Clin Ther. 2009 Jul;31(7):1497-510. doi: 10.1016/j.clinthera.2009.07.018. Review.

PMID:
19695399
14.

Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.

Iwamoto J, Takeda T, Sato Y.

Curr Med Res Opin. 2006 May;22(5):919-28. Review.

PMID:
16709313
15.

[Osteoporosis: Optimizing treatment strategy].

Thomas T.

Presse Med. 2006 Oct;35(10 Pt 2):1543-6. Review. French.

PMID:
17028519
16.

Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss.

Zaidi M, Turner CH, Canalis E, Pacifici R, Sun L, Iqbal J, Guo XE, Silverman S, Epstein S, Rosen CJ.

Curr Osteoporos Rep. 2009 Dec;7(4):118-26. Review.

PMID:
19968915
17.
18.

Long-term experience with alendronate in the treatment of osteoporosis.

Hochberg MC, Rizzoli R.

Expert Opin Pharmacother. 2006 Jun;7(9):1201-10. Review.

PMID:
16732706
19.

Diagnosis and treatment of osteoporosis.

Sweet MG, Sweet JM, Jeremiah MP, Galazka SS.

Am Fam Physician. 2009 Feb 1;79(3):193-200. Review.

20.

Update on postmenopausal osteoporosis management.

Clunie G.

Clin Med. 2007 Jan-Feb;7(1):48-52. Review. No abstract available.

PMID:
17348575
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk